Vumerity Linked to Better Quality of Life Than Tecfidera in RRMS Trial
Vumerity (diroximel fumarate) is easier on the gastrointestinal tract than Tecfidera (dimethyl fumarate), and this translates into better…
Articles by Margarida Maia, PhD
SPMS Patient First To Be Treated With Antibody Given via Nasal Spray
For a first time, an immune-modulating antibody will be given via nasal administration to treat a person with secondary…
National MS Society Encourages Patients to Get COVID-19 Vaccine
Most patients with relapsing and progressive forms of multiple sclerosis (MS) are encouraged to get vaccinated against COVID-19 —…
Ocrevus May Delay by 7 Years PPMS Patients’ Need for Wheelchair
Ocrevus (ocrelizumab) treatment may delay the need for a wheelchair by seven years in patients with primary progressive…
Mavenclad Quickly Reduces MRI Lesions in Early MS, ORACLE-MS Data Show
Mavenclad (cladribine) reduces the number and volume of lesions in patients at risk of multiple sclerosis (MS) after…
Vitamin D Supplements at Preclinical Stage Prevented MS in Mice
Vitamin D, but not paricalcitol (a vitamin D analog), can be used as a preventive measure to control the…
Lipid Signaling Molecule Regulates Immune Responses in Mice
Lipid (fat) molecules can function as chemical couriers, taking messages from tissue to tissue, organ to organ as part of…
Antigen-loaded Red Blood Cells Help Promote Immune Tolerance in Mice
Red blood cells carrying specific antigen proteins on the cell surface can be used to disarm overactive T-cells by promoting…